source
- FDA peptide panel faces clash as Ebola outbreak kills over 1,000 and vaccine options remain limitedThe FDA is holding a two‑day panel on peptide therapeutics, and observers anticipate heated debate among regulators and industry. The African CDC reports the fastest‑growing Ebola outbreak, with m…
- Biopharma firms must prioritize hiring and retaining commercial talent for successful drug launchesA BioSpace webinar brought together commercial leaders and a recruiting specialist to discuss how biopharma companies can better hire and keep commercial staff as they prepare for new product launc…